Expertise
Life Sciences
Public Law Advocacy
Decisions of federal and provincial government organizations, agencies and/or administrative tribunals can impact business strategies and decisions. Our expertise includes advice to, and representation of, clients in matters relating to:
- Health Canada decisions during drug regulatory approval processes
- Health Canada "stop-sale" decisions in respect of approved drugs
- Patent listing and delisting decisions by Health Canada pursuant to the Patented Medicines (Notice of Compliance) Regulations and related policy decisions
- Health Canada decisions under the Patented Medicines (Notice of Compliance) Regulations regarding the issuance of notices of compliance for generic products
- Product listing on provincial drug formularies
- Jurisdictional and procedural decisions of the Patented Medicine Prices Review Board
- Issues raised by the Canadian Intellectual Property Office during patent prosecution of pharmaceutical and biotechnological inventions
- Competition Bureau decisions on trade and pricing
- WTO / NAFTA challenges to government decisions>/li>
- Options and strategies for challenging governmental activity and decisions
